scispace - formally typeset
A

Anne Kallioniemi

Researcher at University of Tampere

Publications -  152
Citations -  24111

Anne Kallioniemi is an academic researcher from University of Tampere. The author has contributed to research in topics: Breast cancer & Comparative genomic hybridization. The author has an hindex of 64, co-authored 151 publications receiving 23405 citations. Previous affiliations of Anne Kallioniemi include Lawrence Livermore National Laboratory & National Institutes of Health.

Papers
More filters
Journal ArticleDOI

Tissue microarrays for high-throughput molecular profiling of tumor specimens

TL;DR: In this paper, an array-based high-throughput technique that facilitates gene expression and copy number surveys of very large numbers of tumors is presented. But, it is limited to a single tumor tissue microarray.
Journal ArticleDOI

Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors

TL;DR: Comparative genomic hybridization produces a map of DNA sequence copy number as a function of chromosomal location throughout the entire genome, which identified 16 different regions of amplification, many in loci not previously known to be amplified.
Journal ArticleDOI

Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors.

TL;DR: Recent optimized procedures for CGH are described, including DNA labeling, hybridization, fluorescence microscopy, digital image analysis, data interpretation, and quality control, emphasizing those steps that are most critical.
Journal ArticleDOI

Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization.

TL;DR: Comparative genomic hybridization was applied to 5 breast cancer cell lines and 33 primary tumors to discover and map regions of the genome with increased DNA-sequence copy-number, indicating that these chromosomal regions may contain previously unknown genes whose increased expression contributes to breast cancer progression.
Journal ArticleDOI

RAD51B in Familial Breast Cancer

Liisa M. Pelttari, +115 more
- 05 May 2016 - 
TL;DR: It is suggested that loss-of-function mutations in RAD 51B are rare, but common variation at the RAD51B region is significantly associated with familial breast cancer risk.